Company Filing History:
Years Active: 2012-2015
Title: Innovations of Inventor Stefan Hubert Schlör
Introduction
Stefan Hubert Schlör is an accomplished inventor based in Marktheidenfeld, Germany. With a focus on advancements in the treatment of disorders related to the central nervous system (CNS) and the eye, he has been granted two significant patents that highlight his contributions to medical science.
Latest Patents
His latest patents include innovative methods for the specific modulation of target genes in the CNS and the eye. These patents provide comprehensive methodologies for developing pharmaceutical compositions aimed at treating disorders affecting these crucial parts of the body. Specifically, the inventions emphasize the administration of compositions outside the blood-CNS and blood-retina barriers to enhance therapeutic efficacy. Furthermore, Schlör's patents detail procedures for identifying and obtaining nucleic acid molecules that encode polypeptides relevant to CNS disorders or eye conditions. This work extends to diagnosing such disorders and includes the creation of transgenic animals that exhibit deficiency in specific target genes. Additionally, new methods for discovering and isolating drugs particularly effective for treating CNS or eye-related disorders are disclosed.
Career Highlights
Throughout his career, Stefan Schlör has worked with notable companies in the pharmaceutical sector, including Acuity Pharmaceuticals, Inc. and Opko Pharmaceuticals, LLC. His roles in these organizations have reinforced his expertise in pharmacological innovation and gene modulation.
Collaborations
Collaboration has played a critical role in Schlör's development as an inventor. He has worked alongside professionals such as Karina Drumm and Frank Göhring, contributing to advancements in research and development within the field of CNS and ocular therapies.
Conclusion
Stefan Hubert Schlör’s innovative patents underscore his commitment to addressing complex medical challenges related to the CNS and the eye. His work not only enhances our understanding of gene modulation but also offers promising avenues for developing effective treatments for disorders, signifying his impact in the realm of medical innovation.